Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
280M
-
Shares change
-
+9.37M
-
Total reported value, excl. options
-
$541M
-
Value change
-
+$18.8M
-
Put/Call ratio
-
1.25
-
Number of buys
-
55
-
Number of sells
-
-66
-
Price
-
$1.93
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q3 2024
168 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q3 2024.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 280M shares
of 374M outstanding shares and own 74.89% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (71.3M shares), VIKING GLOBAL INVESTORS LP (58.7M shares), BlackRock, Inc. (22.5M shares), VANGUARD GROUP INC (17.3M shares), MORGAN STANLEY (15.2M shares), Sumitomo Mitsui Trust Group, Inc. (9.58M shares), Nikko Asset Management Americas, Inc. (9.57M shares), ARK Investment Management LLC (8.95M shares), MILLENNIUM MANAGEMENT LLC (6.98M shares), and GEODE CAPITAL MANAGEMENT, LLC (6.95M shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.